Ginkgo Biloba For The Treatment Of Vitilgo Vulgaris: An Open Label Pilot Clinical Trial
| Effect | Decrease |
| Trial Design | Non-controlled trial |
| Trial Length | 1-6 months |
| Number of Subjects | 11 |
| Sex | Both Genders |
| Age Range | 13-17, 18-29, 30-44 |
Symptoms of vitilgo vulgaris appear to be reduced with 12 weeks supplementation of 120mg EGb-761 daily, associated with a 15% skin repigmentation rate and 0.4% reduced lesion size.
